GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pulike Biological Engineering Inc (SHSE:603566) » Definitions » 12-1 Month Momentum %

Pulike Biological Engineering (SHSE:603566) 12-1 Month Momentum % : -28.06% (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pulike Biological Engineering 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-26), Pulike Biological Engineering's 12-1 Month Momentum % is -28.06%.

The industry rank for Pulike Biological Engineering's 12-1 Month Momentum % or its related term are showing as below:

SHSE:603566's 12-1 Month Momentum % is ranked worse than
52% of 1477 companies
in the Biotechnology industry
Industry Median: -25.71 vs SHSE:603566: -28.06

Competitive Comparison of Pulike Biological Engineering's 12-1 Month Momentum %

For the Biotechnology subindustry, Pulike Biological Engineering's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulike Biological Engineering's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's 12-1 Month Momentum % falls into.



Pulike Biological Engineering  (SHSE:603566) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulike Biological Engineering  (SHSE:603566) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Pulike Biological Engineering 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Pulike Biological Engineering's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulike Biological Engineering (SHSE:603566) Business Description

Traded in Other Exchanges
N/A
Address
15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
Executives
Sun Jin Zhong Director
Zhang Zhen Supervisors
Wang Zhu Yi Supervisors
Ma Sui Ying Director
Song Yong Jun Director
Hu Wei Director
Qiao Rong Cen senior management
Zhou Li Peng senior management
Tian Ke Gong senior management
Kang Du Li senior management
Zhao Rui senior management
Qin De Chao Director
Pei Lian Feng senior management
Zhang Li Chang Director
Zhang Xu Ke Director

Pulike Biological Engineering (SHSE:603566) Headlines

No Headlines